Quotes

Back To Menu

Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

Invest

22 Sep 2017 | 03:59 PM

2,428.05
-9.80 (-0.40%)

  • Outperforms Index

    -13.13%

    Return (1Y)

    Beaten S&P BSE Healthcare by 3.72%

  • Less Volatile

    0.87%

    Standard Deviation (1Y)

    Lower than S&P BSE Healthcare by 0.22%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

3,000

2,999.90

2,309

2,309.05

News & Announcements

  • Board of Glaxosmithkline Pharmaceuticals approves sale of land in Thane

    1 day ago

  • Glaxosmithkline Pharmaceuticals standalone net profit declines 63.44% in the June 2017 quarter

    61 days ago

  • Glaxosmithkline Pharma to hold board meeting

    86 days ago

  • Glaxosmithkline Pharma standalone net profit rises 6.29% in the March 2017 quarter

    128 days ago

Price vs Volume

Stock Trivia

  • Glaxosmithkline Pharma Ltd has given the 2nd best dividend yield 1.83 for 1 Year among stocks in Pharmaceuticals Sector

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -20.92% since past 1 Year

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 7.08% since past 1 Year

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...